BacTrace® E. coli O104/O91 Antibodies offer assay developers and researchers antibodies to detect the E. coli O104/O91 serotypes* with high specificity and sensitivity. When compared to monoclonal antibodies, BacTrace® E. coli O104/O91 antibodies are more sensitive, while offering high serotype specificity. BacTrace® E. coli O104/O91 antibody benefits include:
• Utilizes industry-proven ECAP (Encapsulated Column Affinity Purification )
• High serotype specificity
• Goat polyclonal antibodies provide greater sensitivity, when compared to monoclonals
• New antibodies detect emerging STEC strains O104 (implicated in the German outbreak of 2011) and O91 (frequently isolated from food and patients)
• Suited for a variety of immunodetection and immunoselection applications
• Also available in bulk size, scalable manufacturing
* Note: Food pathogens. In Mai/June 2011, Shiga-like toxin-producing Escherichia coli (STEC) serotype O104:H4 caused an outbreak of 855 cases of Hemolytic-Uremic Syndrome (HUS) as well as 3.000 cases of acute gastroenteritis and bloody diarrhea in Germany.

• Homepage Download BacTrace brochure